Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.
Project leader/senior scientist at UniBern.
2 years in pharma industry.
8 years of research activity on the ECS
Full Professor at UniBern.
Collaboration with pharma industry.
10+ years of research activity on the ECS.
Updated: Oct 25, 2021
Synendos Therapeutics participates at the Bio€quity Europe Digital 2021, taking place online on May 17-19, 2021 (https://conferences.biocentury.com/bioequity-europe). We are looking forward to this virtual gathering of the corporate investment communities for the European life sciences.
Andrea Chicca (CEO) and Simon Russell (CCO) are attending the BioEquity Europe conference in Bruges from May 12th to May 14th, 2025.
Andrea Chicca (CEO) and Simon Russell (CCO) are attending the Swiss Biotech Days, May 5th - 6th in Basel, Switzerland.
Synendos has been selected for the Bio-Neuroscience Award for the "Best Pitch" after our CEO Andrea Chicca's presentation on our clinical...